
Zeda
Advanced manufacturing for medical and regulated industries.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | $52.0m | Series B | |
Total Funding | 000k |
Zeda, Inc., formerly known as PrinterPrezz, operates as a technology solutions company specializing in advanced manufacturing for highly regulated industries. The company was founded in 2018 by CEO Shrinivas (Shri) Shetty, whose background in chemical engineering and experience at Applied Materials inspired him to apply advanced manufacturing and semiconductor technologies to the medical device sector. Initially focused on creating next-generation orthopedic and spinal implants by combining metal 3D printing, nanotechnology, and surgical expertise, the company has since expanded its scope.
A key milestone was the October 2021 acquisition of Vertex Manufacturing, a Cincinnati-based advanced manufacturer founded by additive manufacturing pioneer Greg Morris. This merger integrated crucial post-processing technologies and broadened the company's market reach beyond medical devices to include aerospace, defense, space, and energy sectors. Following this strategic growth, PrinterPrezz and Vertex rebranded as Zeda in March 2023 to represent their unified capabilities and customer-focused approach. Greg Morris now serves as the Chief Technology Officer (CTO).
Zeda provides an end-to-end manufacturing platform, from concept design and rapid prototyping to FDA approval and volume production. The firm's proprietary "Medifacturing" workflow converts MRI and CT scans into 3D printable models, enabling the creation of customized medical devices. The business model serves a diverse client base, from individual innovators to multinational corporations, offering access to a wide array of 3D printing machines, advanced software, and nanocoating technologies. The company operates out of over 140,000 square feet of manufacturing space across facilities in California, Ohio, New Jersey, and Singapore.
Zeda has secured significant funding to fuel its expansion, including a $16 million Series A round in December 2020 and a $52 million Series B round in March 2023, bringing its total capital raised to $68 million. These funds are being used to expand its advanced manufacturing digital foundry in Cincinnati and increase its global footprint, particularly in the Asian medical implant market.
Keywords: additive manufacturing, medical devices, 3D printing, nanotechnology, orthopedic implants, spinal implants, regulated industries, aerospace manufacturing, defense manufacturing, advanced manufacturing, semiconductor technology, medifacturing, metal 3D printing, custom implants, medical technology, rapid prototyping, contract manufacturing, nanocoating, surgical solutions, digital foundry